Continuing its manufacturing revamp, Pfizer unloads another Tennessee plant

Pfizer ($PFE) sold a former King Pharmaceuticals plant, acquired along with that company in 2011, to UPM Pharmaceuticals as part of an effort to streamline its manufacturing. UPM's top leadership is familiar with the Bristol, TN, facility; CEO John Gregory started King Pharma back in 1994. Report

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.